Angiotensin II Blockade for Chronic Allograft Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Kidney DiseaseProteinuria
Interventions
DRUG

Losartan 100mg

To be started within three months of transplant and continued for five years.

DRUG

Placebo

No treatment with continued follow-up for five years.

Trial Locations (2)

55415

Hennepin County Medical Center, Minneapolis

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Minnesota

OTHER

NCT00067990 - Angiotensin II Blockade for Chronic Allograft Nephropathy | Biotech Hunter | Biotech Hunter